silver has been researched along with Cardiometabolic Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alqahtani, S; Shannahan, JH; Xia, L | 1 |
| Alqahtani, S; Coltellino, V; Kishman, R; Kobos, L; McIlrath, D; Perez-Torres, C; Shannahan, J; Xia, L | 1 |
| Alqahtani, S; Du, X; Ferreira, C; Franco, J; Kobos, LM; Shannahan, JH; Xia, L | 1 |
3 other study(ies) available for silver and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Enhanced silver nanoparticle-induced pulmonary inflammation in a metabolic syndrome mouse model and resolvin D1 treatment.
Topics: Animals; Cytokines; Disease Models, Animal; Docosahexaenoic Acids; Inflammation; Metabolic Syndrome; Metal Nanoparticles; Mice; Pneumonia; Silver | 2022 |
Comparison of silver nanoparticle-induced inflammatory responses between healthy and metabolic syndrome mouse models.
Topics: Animals; Disease Models, Animal; Inflammation; Male; Metabolic Syndrome; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Oxidative Stress; Silver; Tissue Distribution | 2020 |
Exacerbation of Nanoparticle-Induced Acute Pulmonary Inflammation in a Mouse Model of Metabolic Syndrome.
Topics: Animals; Atorvastatin; Diet, High-Fat; Diet, Western; Disease Models, Animal; Disease Susceptibility; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Male; Metabolic Syndrome; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Pneumonia; Real-Time Polymerase Chain Reaction; RNA, Messenger; Silver; Treatment Outcome | 2020 |